LABTRACE.ORG BETA LIVE
240 source polls this hour 39 310 articles collected last article 2m ago 634 events on 2+ sources 0 embeddings/h feed queue 0 lag 382.0s
← health
LT-004818 / first seen 2026-08-07 19:22 / last activity 34d ago solid / under-covered

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial

measurement

heat
2 / 100 (raw 0.0)
velocity
0.0 independent sources per hour
solidity
97 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
venue
The Lancet
status
peer-reviewed
doi
10.1016/s0140-6736(26)01092-5
published
2026-08-01

media coverage / 1 outlets